Particella, Inc.

๐Ÿ“ San Francisco, United States๐Ÿ—“ Founded 2016๐Ÿ‘ฅ 6 employees๐Ÿ’ฐ Last funded 2018
Particella Inc., (formerly DNAlite Therapeutics) is a biotechnology company that has developed a novel proprietary lipid nanoparticle that can deliver mRNA and other nucleic acids orally.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Particella, Inc.?
Particella, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Particella, Inc. last raise funding?
The most recent investment in Particella, Inc. recorded on gritt.io was in 2018.
When was Particella, Inc. founded?
Particella, Inc. was founded in 2016.
What industry is Particella, Inc. in?
Particella, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Particella, Inc. based?
Particella, Inc. is headquartered in San Francisco, United States.